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Background: Glucagon stimulates liver respiration.
Results: SCaMC-3 is the only functional mitochondrial ATP-Mg/Pi carrier in adult liver and SCaMC-3 deficiency prevents
glucagon effects in hepatocytes and in vivo.
Conclusion: SCaMC-3 is required for the stimulation of oxidative phosphorylation in response to glucagon through a Ca2-
dependent increase of mitochondrial adenine nucleotides and Ca2 retention.
Significance: Ca2 stimulation of SCaMC-3 is required for liver response to glucagon.
It has been known for a long time that mitochondria iso-
lated from hepatocytes treated with glucagon or Ca2-mobi-
lizing agents such as phenylephrine show an increase in their
adenine nucleotide (AdN) content, respiratory activity, and
calcium retention capacity (CRC). Here, we have studied the
role of SCaMC-3/slc25a23, the mitochondrial ATP-Mg/Pi
carrier present in adult mouse liver, in the control of mito-
chondrial AdN levels and respiration in response to Ca2 sig-
nals as a candidate target of glucagon actions. With the use of
SCaMC-3 knock-out (KO) mice, we have found that the car-
rier is responsible for the accumulation of AdNs in liver mito-
chondria in a strictly Ca2-dependent way with an S0.5 for
Ca2 activation of 3.3  0.9 M. Accumulation of matrix
AdNs allows a SCaMC-3-dependent increase in CRC. In addi-
tion, SCaMC-3-dependent accumulation of AdNs is required
to acquire a fully active state 3 respiration in AdN-depleted
liver mitochondria, although further accumulation of AdNs
is not followed by increases in respiration. Moreover, gluca-
gon addition to isolated hepatocytes increases oligomycin-
sensitive oxygen consumption and maximal respiratory rates
in cells derived from wild type, but not SCaMC-3-KO mice
and glucagon administration in vivo results in an increase in
AdN content, state 3 respiration and CRC in liver mitochon-
dria in wild type but not in SCaMC-3-KO mice. These results
show that SCaMC-3 is required for the increase in oxidative
phosphorylation observed in liver mitochondria in response
to glucagon and Ca2-mobilizing agents, possibly by allowing
a Ca2-dependent accumulation of mitochondrial AdNs and
matrix Ca2, events permissive for other glucagon actions.
During fasting, glucagon secreted by -cells in the pancreas
activates a complex metabolic response in liver cells that
includes glycogen breakdown, gluconeogenesis, urea synthesis,
uptake of adenine nucleotides (AdNs),5 and increase in the
Ca2 retention capacity (CRC) of the mitochondria, and stim-
ulation of oxidative phosphorylation (OXPHOS) (1, 2).
Although the primary pathway of glucagon action involves
binding of the hormone to a G-protein-coupled receptor and
formation of cAMP through activation of adenylate cyclase, a
cytosolic Ca2 signal is also produced both by release of intra-
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cellular stores and Ca2 entry in the cell (3). Inhibition of this
Ca2 signal has been shown to block the increase in mitochon-
drial AdN content after glucagon treatment (4), thereby reduc-
ing matrix availability for AdN-dependent reactions, including
OXPHOS (5). Two different mechanisms have been proposed
to mediate the mitochondrial uptake of AdNs by Ca2. In the
first, entry of cytosolic Ca2 into the mitochondria would
inhibit the matrix pyrophosphatase, leading to an increase in
pyrophosphate that would then be exchanged by cytosolic
AdNs through the ATP/ADP translocase (ANT) (6). The sec-
ond mechanism, proposed by Aprille and co-workers (7, 8),
involves the ATP-Mg/Pi carrier, a Ca2-dependent mitochon-
drial carrier that has been recently identified at the molecular
level (9, 10).
Due to its structure, with Ca2-binding EF-hand domains
facing the intermembrane space, the ATP-Mg/Pi carrier is acti-
vated by Ca2 signals that do not require entry of the cation in
the mitochondria (reviewed in Ref. 11). To date, five different
paralogs, termed SCaMC (short calcium-binding mitochon-
drial carrier) 1–3, -1-like and -3-like, have been described in
mammals (9, 10, 12–14), of which two, SCaMC-1-like and
SCaMC-3-like, are only expressed in testis. In addition, several
splicing isoforms have been described (9), making it the most
complex subgroup of mitochondrial carriers (15). The trans-
port activity catalyzed by the SCaMCs is the electroneutral and
reversible exchange of ATP-Mg2 or HADP2 with HPO42
(16). Unlike the ANT, the ATP-Mg/Pi carrier does not inter-
change AdNs between the cytoplasm and the mitochondria,
but rather increases or decreases the net mitochondrial AdN
content.
In this work we have studied the role of SCaMC-3/Slc25a23,
the main paralog of the ATP-Mg/Pi carrier in liver, in mito-
chondrial function in response to Ca2-mobilizing agonists
glucagon and phenylephrine.With the use of SCaMC-3 knock-
out (KO)mice, we have found that the carrier is responsible for
the accumulation of AdNs in liver mitochondria in a strictly
Ca2-dependent way, with an S0.5 for Ca2 activation of 3.3
0.9M, and that SCaMC-3-dependent accumulation ofAdNs is
required to increase mitochondrial CRC and acquire a fully
active state 3 respiration in liver mitochondria. Moreover, glu-
cagon addition to isolated hepatocytes increases oligomycin-
sensitive oxygen consumption in cells derived from wild type,
but not SCaMC-3-KO mice, and in vivo glucagon administra-
tion results in an increase inAdNcontent, CRC, and respiratory
capacity in liver mitochondria, mediated by SCaMC-3. These
results reveal an important role of SCaMC-3 as a target ofCa2-
mobilizing agents in liver by modulating OXPHOS.
EXPERIMENTAL PROCEDURES
Animals—Mice deficient in SCaMC-3 were generated by
Lexicon with amixed C57BL6/Sv129 genetic background. Ani-
mals are born in mendelian proportions and show no evident
phenotypic traits. Genotyping was performed by double PCR
using primers 9 (forward, 5-TGAGGCATGAGGCATATT-
CTA-3) and 10 (reverse, 5-AAGGCTGTGAAACATGAGCA-
3) to detect the wild type allele, and primers Neo3a (forward,
5-GCAGCGCATCGCCTTCTATC-3) and 12 (reverse, 5-
GGGCTAGCTGTATTACCAGTC-3) to detect the targeted
locus. Products were resolved by electrophoresis in 1.5% aga-
rose gels and identified by their fragment sizes. All animal work
performed in this study was carried out in accordance with
procedures approved in the Directive 86/609/EEC of the Euro-
pean Union and with approval of the Ethics Committee of the
Universidad Autónoma deMadrid. Glucagon (2mg/kg; Sigma)
was injected intraperitoneally in fed 3–5-month-old male mice
and animals were sacrificed by cervical dislocation 15min after
administration.
Metabolic Measurements—Glucose was measured using a
blood dropper with Accutrend stripes. Blood serum was
obtained from 2–3-month-old wild type and SCaMC-3-KO
mice and urea wasmeasured using a commercial kit (Spinreact,
Barcelona).
Hepatocytes Isolation and Culture—Hepatocytes were iso-
lated as previously described (17). Briefly, livers from 12-h
fasted 3–5-month-old male mice were perfused with Hanks’
balanced salt solution supplemented with 10mMHepes and 0.2
mM EGTA for 5 min, followed by a longer perfusion (10–15
min) with William’s medium E containing 10 mM Hepes and
0.03% collagenaseH (0.19 units/mg; Sigma). Liverswere further
minced and viable hepatocytes were selected by centrifugation
in Percoll, and seeded in collagen I-coated plates at a density of
0.6  106 cells/cm2 in Dulbecco’s modified Eagle’s medium/
F-12 (1:1). Cells were kept overnight at 37 °C and 5% CO2, and
used 12–16 h later.
Western Blot and Antibodies—Protein samples were col-
lected in extraction buffer (250mM sucrose, 1 mM EDTA, 1mM
EGTA, 25 mM Hepes, 10 mM KCl, 1.5 mM MgCl2, 1 mM DTT,
0.1% BSA, pH 7.4, containing protease inhibitors), disrupted by
sonication and quantified. Samples were resolved in SDS-
PAGE using 10% gels, transferred to nitrocellulosemembranes,
and incubated with the indicated primary antibodies. Rabbit
polyclonal antibodies against SCaMC-1, -2, and -3 were used at
a dilution of 1:5,000, as previously described (9). Mouse mono-
clonal Hsp60 antibody (Sigma) and rabbit polyclonal-ATPase
antibody (a kind gift fromDr. J. M. Cuezva, CBMSO)were used
at a dilution of 1:10,000. Peroxidase-coupled secondary anti-
bodies were used and proteins were visualized with a chemilu-
minescence detection kit (ECL, PerkinElmer, Waltham, MA).
Mitochondria Isolation—For oxygen consumption measure-
ments and transport assays, livermitochondria were isolated as
previously described (18). Final pellets were resuspended in
MSK buffer (75mMD-mannitol, 25mM sucrose, 5mMKH2PO3,
20 mM Tris-HCl, 0.5 mM EDTA, 100 mM KCl, and 0.1% BSA
fatty acids free, pH 7.4). Muscle mitochondria were extracted
from hindlimbs in 100 mM sucrose, 9 mM EDTA, 1 mM EGTA,
100 mM Tris-HCl, 46 mM KCl, pH 7.4, and incubated with pro-
tease Nagarse (0.4 mg/ml, 10 min; Sigma) prior to homogeni-
zation. For heart mitochondria, the procedure was the same as
for muscle, but a different buffer was used (230 mM mannitol,
70 mM sucrose, 1 mM EDTA, 5 mM Tris-HCl, pH 7.4).
ATP-Mg Transport Assays and AdNQuantification—Trans-
port assays were performed with 0.5 mg of mitochondria in
transportmedium (225mM sucrose, 2mMKH2PO4, 4mMATP,
5 mM MgCl2, 10 mM Tris-HCl, 200 nM ruthenium red (RR), 5
mM succinate, pH 7.4, at 30 °C in the presence of 1mMEGTAor
20 M CaCl2 for different lengths of time. The reactions were
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stopped by addition of 1.5 volumes of ice-cold transport
medium devoid of succinate and supplemented with 1 mM
EGTA.Mitochondria were centrifuged at 14,000 g for 5 min,
and washed twice in the same medium. AdNs were extracted
frompellets by incubationwith 10%HClO4 for 60min. Extracts
were centrifuged and neutralized using KOH.
To evaluate the Ca2 dependence of the transport, wild type
mitochondria were incubated in transport mediumwith differ-
ent concentrations of CaCl2 for 30 s and processed as above.
The differentCa2 concentrationswere prepared using EGTA-
Ca2 buffers (19). The free Ca2 in each medium was deter-
mined, in the presence of mitochondria and all reactants with
0.1MCalciumGreen (Molecular Probes, Invitrogen) using the
equation [Ca2]  Kd (F  Fmin)/(Fmax  F), where F is the
fluorescence of the medium, Fmax and Fmin are determined in
each case by adding saturating amounts of CaCl2 (Fmax) or
EGTA-Tris, pH 8 (Fmin), andKd is 14M (20). Fluorescencewas
measured in a FluoSTAROPTIMAmicroplate reader (ex/em
 506/532 nm).
Total ATPwas quantified usingATPBioluminescenceAssay
Kit CLS II (Roche Applied Science) with a FLUOstar OPTIMA
microplate reader. ADP was measured by conversion to ATP
using 2.5 mM phosphocreatine and 4 units of phosphocreatine
kinase. AdN levels were also determined by HPLC. To this end,
mitochondrial samples were treated with 10% HClO4 over-
night, neutralized using K2CO3, kept on ice 10min, and then at
80 °C for 1 h to allow precipitation of HClO4. Extracts were
centrifuged and 50 l of the supernatants were injected for
AdN determination (21). To determine the identity of each
peak and quantify the amount of the species of interest, stand-
ard curves were constructed by plotting peak heights versus
known concentrations of ATP, ADP, and AMP (22).
Oxygen Consumption Measurements—Respiratory rates in
isolatedmitochondriawere determined using aClark-type oxy-
gen electrode (Hansatech Instruments Ltd., Norfolk, UK) as
described previously (23). Measurements were performed at
30 °C in MSK buffer supplemented with 1 mM EGTA unless
noted otherwise, using 0.3–0.4 mg of protein. State 4 respira-
tion was assayed in 5 mM glutamate plus malate or 2 M rote-
none plus 5 mM succinate. State 3 was initiated by the addition
of 0.5 or 2 mM ADP. To confirm that state 3 was dependent on
ATP synthase activity, 6M oligomycin was added to the mito-
chondrial suspension, which resulted in the same respiratory
rates as before ADP addition. At the end of each assay, 1–5 M
carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone
(FCCP) or 40–80 M dinitrophenol (when mitochondria were
respiring glutamate plus malate) was added to uncouple mito-
chondria and obtain maximal respiration, confirming mem-
brane integrity. In both cases, titrations were carried out to
obtain maximal respiratory rates. With the exception of exper-
iments using AdN-depleted mitochondria, uncoupled rates
were similar to state 3 respiration as previously described (24).
Respiratory control ratios were obtained by dividing state 3 by
state 4 respiratory rates, which were corrected by subtracting
unspecific rates obtained before substrate addition.
In some experiments mitochondria were depleted of AdNs
by incubation in MSK with 2 mM tetrasodium pyrophosphate
for 5 min at 30 °C (25, 26), centrifuged at 10,000 g for 5 min,
and resuspended in fresh MSK. AdN depletion was confirmed
by measuring oxygen consumption in the presence of 1 mM
EGTA, as depleted mitochondria are unable to stimulate respi-
ration after ADP addition (7). For the filling reactions with
ATP-Mg, mitochondria were incubated in MSK devoid of
EDTA and supplemented with 200 nM RR and the indicated
concentrations of ATP andMgCl2, at 30 °C for different lengths
of time. The free Ca2 concentration of themediumwas deter-
mined fluorimetrically in the presence of mitochondria, all
reactants, and 0.1 M Calcium Green-5N. Incubations were
stopped by introducing the samples in ice, centrifuged
(10,000  g, 5 min) and resuspended in the MSK with 1 mM
EGTA for oxygen measurements or 10% HClO4 for AdN
quantification.
To assess oxygen consumption in intact attached cells, hepa-
tocytes were plated in XF24 V7 cell culture plates and a Sea-
horse Bioscience XF24–3 Analyzer (Seahorse Bioscience, Bil-
lerica, MA) was used as previously described (27). Before
measurements, cell medium was replaced by assay medium
(bicarbonate-freeDMEM/F-12 (1:1) supplementedwith 10mM
sodium lactate and 5 mM glucose) and plates were equilibrated
at 37 °C for 60 min. After baseline measurement, one of the
following agonists was injected: 0.1 M glucagon (Sigma), 100
M phenylephrine (Sigma), or vehicle. Subsequently, all wells
were injected sequentially with 6 M oligomycin, 1 M FCCP,
and 1 M antimycin A plus 1 M rotenone to obtain different
respiratory parameters.
Ca2Uptake in IsolatedMitochondria—TheCRCof isolated
mitochondria wasmeasured with 0.1MCalciumGreen-5N as
an extramitochondrial Ca2 indicator inMSK devoid of EDTA
and supplemented with 1 mM MgCl2 as previously described
(28). An Aminco-Bowman fluorimeter provided with temper-
ature control and continuous stirringwas used.All experiments
were carried out at 30 °C in the presence of respiratory sub-
strates (5 mM succinate 2 M rotenone) and in the presence
or absence of AdNs (ATP or ADP). After 3–5 min of incuba-
tion, mitochondria were challenged with subsequent 10–20
nmol of CaCl2 additions as indicated in the figure legends, and
Ca2 uptake into mitochondria was measured as a decrease in
fluorescence. The CRC was determined as the total amount of
Ca2 (in nmol permgof protein) that themitochondria are able
to take up before starting to release it to the extramitochondrial
medium.
Cytosolic Ca2 Measurements—To monitor cytosolic Ca2
signals, hepatocytes growing on coverslips were loaded with 5
M Fura-2-AM (Molecular Probes, Invitrogen) for 15 min at
37 °C in Ca2-free HCSS medium (120 mM NaCl, 0.8 mM
MgCl2, 25 mM Hepes, and 5.4 mM KCl) supplemented with
0.05% pluronic acid F-127 (Invitrogen) and washed for 20 min
at 37 °C in HCSS with 2 mM CaCl2. Coverslips were then
mounted in the perfusion chamber of a Zeiss microscope as
previously described (29), and fluorescence was imaged ratio-
metrically at 37 °C using alternate excitation at 340 and 380 nm
and a 510-nm emission filter with a Neofluar 40/0.75 objec-
tive. Agonists were added as a bolus. Image acquisition and
analysis were performed using Aquacosmos 2.6 software
(Hamamatsu Photonics, Hamamatsu, Japan). Ratio signals
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were converted to Ca2 concentrations using the calculations
described in Ref. 20.
RESULTS
SCaMC-3 Is theOnly FunctionalATP-Mg/Pi Carrier inAdult
Liver—SCaMC-3-KO and SCaMC-3 heterozygous mice are
born inmendelian proportions andhave no obvious phenotype,
similar to what has been described for SCaMC-2-KOmice (30).
Table 1 shows that SCaMC-3-KO mice have normal glucose,
but reduced plasma urea levels.
To study whether a compensatory effect is taking place in
SCaMC-3-KO animals, we analyzed the protein levels of the
other paralogs of the ATP-Mg/Pi carrier in mitochondria from
different adult tissues. The SCaMC-3 signal was found in liver
and brain, but not in heart or muscle mitochondria (Fig. 1A),
whereas SCaMC-2 and SCaMC-1 were only detected in brain,
but not liver. There was no up-regulation of either of these
paralogs in mitochondria from SCaMC-3-KO mice. SCaMC-3
levels in late embryonic and early postnatal liver are much
lower than in adult liver (Fig. 1B). At these stages, SCaMC-1
showed high levels from E14–E18 until P1, being almost negli-
gible in adult liver, whereas SCaMC-2 expression was not
detected (results not shown). Again, no changes in SCaMC-1
levels were detected in embryonic liver mitochondria from
SCaMC-3-KO mice.
To study the effect of the lack of SCaMC-3 in mitochondrial
respiration, liver mitochondria from wild type and SCaMC-
3-KOmice were incubated with 5mM glutamate plus malate or
2 M rotenone plus 5 mM succinate in a Ca2-free medium, in
the absence or presence of 0.5 mMADP. Respiratory rates in all
conditions, as well as respiratory control ratios, were similar in
both genotypes, indicating lack of abnormalities in electron
transport chain activity and OXPHOS in SCaMC-3-deficient
mitochondria (Fig. 1C).
SCaMC-3 Catalyzes the Transport of ATP-Mg in Isolated
Liver Mitochondria in a Ca2-dependent Manner—SCaMC-3
has been shown to transport ATP-Mg and ADP in exchange
with Pi in reconstituted proteoliposomes, but theCa2 depend-
ence of this transport has not been characterized (10). We per-
formed transport assays incubating wild type and SCaMC-
3-KO liver mitochondria with 4 mM ATP for different lengths
of time. Wild type mitochondria show a time-dependent accu-
mulation of ATP, which requires Ca2, as it does not take place
when EGTA is present in the medium (Fig. 1D, left panel). No
ATP accumulation is observed in SCaMC-3-deficient mito-
chondria, regardless of whether Ca2 is present or not (Fig. 1D,
left panel). These results indicate that the transport of ATP-Mg
in livermitochondria is catalyzed by SCaMC-3 by amechanism
that requires Ca2. In another set of experiments the Ca2
affinity of ATP-Mg uptake was studied by carrying out assays at
different external Ca2 concentrations. An S0.5 for Ca2 acti-
vation of 3.3  0.9 M was obtained (Fig. 1D, right panel). In
both experiments RR was present in the medium to prevent
Ca2 accumulation in the mitochondria.
CRC Is Impaired in SCaMC-3-deficient Mitochondria—In
the case of SCaMC-1, the mitochondrial ATP-Mg/Pi trans-
porter found in cancer cells, and the uptake of AdNs through
the carrier dramatically increases Ca2 retention in mitochon-
dria (28). Therefore, we wondered if the absence of SCaMC-3
affects CRC inmitochondria. To test this possibility, livermito-
chondria fromwild type and SCaMC-3-KO animals were incu-
bated in the absence of AdNs or in the presence of ATP-Mg or
ADP at low (0.2 mM) or physiological (1 mM) concentrations
(Fig. 2). In the absence of AdNs, the CRC is similar in both
genotypes, and so is the Ca2 uptake rate (notice the identical
slopes after Ca2 addition). Addition of 0.2 mM ADP (or ATP-
Mg, not shown) to themedium substantially increases the CRC
ofmitochondria in both genotypes, most likely by amechanism
mediated by the ANT (31). However, when 1 mM ATP-Mg (or
ADP, not shown) is present in the medium, wild type mito-
chondria show a marked increase in the CRC, with no changes
in the initial Ca2 uptake rates, whereas SCaMC-3-deficient
mitochondria are unable to accumulate higher amounts of
Ca2, presumably due to their inability to take up AdNs
through SCaMC-3. The existence of a site for regulation ofCRC
with lower affinity for AdNs than the ANT, and insensitive to
carboxyatractyloside has been suggested (32, 33, 34). We have
proposed elsewhere (28) that the ATP-Mg/Pi carrier could be
responsible for this site of regulation of the CRC, and hypothe-
sized that calcium retention might be increased in mitochon-
dria by allowing the formation of calcium-phosphate
precipitates.
ATP-Mg or ADPUptake in AdN-depletedMitochondria Reg-
ulates Coupled Respiration through Extramitochondrial Ca2-
dependent SCaMC-3 Activity—Alterations in the mitochon-
drial AdN pool have been shown to regulate state 3 respiration
in livermitochondria (25). Incubationwith high concentrations
of pyrophosphate promotes the efflux ofmatrix ATP, ADP, and
AMP in exchange with external pyrophosphate through the
ATP/ADP translocase, leading to a depletion of mitochondrial
AdNs (25, 26). In these conditions, state 4 is increased (35), state
3 cannot be induced due to the lack of matrix ATP to be
exchanged by external ADP through the ANT, and only the net
uptake of ADP or ATP, both of which are transported by the
ATP-Mg/Pi carrier, can restore coupling between electron
transport activity and OXPHOS (25).
To study the influence of SCaMC-3-mediated AdN uptake
on ADP-stimulated respiration we first depleted mitochondria
fromAdNs by incubation with pyrophosphate, and then evalu-
ated oxygen consumption. In the presence of extramitochon-
drial Ca2 (3–4M), addition of 2 mMADP stimulates oligo-
mycin-sensitive respiration in AdN-depleted mitochondria
from wild-type but not SCaMC-3-KOmice, whereas no differ-
ences were observed in uncoupled respiration between geno-
types (Fig. 3A). Matrix Ca2 is not required, as the effect is
observed in the presence of 200 nM RR to inhibit Ca2 accumu-
lation by themitochondria. However, extramitochondrial Ca2
is strictly required for the stimulation, as addition of 2mMADP
TABLE 1
Glucose and urea levels fromwild type and SCaMC-3-KOmice
Levels were determined in 2–3-month-old mice as indicated under “Experimental
Procedures.” Results are expressed as mean S.E. of 10–15 animals.
SCaMC-3WT SCaMC-3 KO
Glucose (mg/dl) 211.5 7.8 196.2 7.0
Urea (md/dl) 31.65 2.13 24.6 2.1a
a p 0.05; unpaired, two-tailed Student’s t test.
SCaMC-3 Is aMitochondrial Target of Glucagon
7794 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 11•MARCH 15, 2013










in the presence of 1 mM EDTA and 1 mM EGTA fails to induce
state 3 respiration (Fig. 3B). In this last condition (i.e. AdN-
depleted mitochondria in Ca2-free medium), state 4 respira-
tory rates are increased as previously described (35), both in
wild type and SCaMC-3-deficient mitochondria. However,
stimulation of the respiration can still be achieved, as mito-
chondria increase their respiratory rates in response to FCCP
(Fig. 3B). Taken together, these results indicate that matrix
AdNs are required to achieve state 3 but not fully uncoupled
respiration.
Although the ATP-Mg/Pi carrier can transport both
ATP-Mg and ADP in isolated mitochondria and reconstituted
liposomes, it has been shown that ATP-Mg is the preferred
substrate under normal energized conditions, as the cytosolic
ATP concentration exceeds that of ADP (36). To study the res-
piratory effect of ATP-Mg uptake in AdN-depleted mitochon-
dria, these were incubated at 30 °C in the presence of 2 mM
ATP, 5 mMMgCl2, and 200 nM RR for different lengths of time,
and then the ADP-response to oxygen consumption in the
presence of 1 mM EGTA was evaluated. After 1 min of incuba-
tion, wild type but not SCaMC-3-KO mitochondria showed a
slight nonsignificant decrease in state 4 respiratory rates (Fig.
4A, state 4) and an increase in state 3 respiration, which was
maximum after 2 min (Fig. 4A, state 3). This is reflected in a
gradual increase in respiratory control ratios, but not in uncou-
pled respiration (Fig. 4A, uncoupled), which occurs in wild type
but not SCaMC-3 deficientmitochondria (Fig. 4A,RCR). These
results indicate that extramitochondrial Ca2-dependent AdN
uptake through SCaMC-3 couples electron transport chain
activity and OXPHOS in isolated mitochondria after AdN
depletion.
To study the consequences of ATP-Mg uptake in normal,
nondepleted organelles, liver mitochondria from wild type and
SCaMC-3-KO mice were incubated with 10 mM ATP and 10
mM Mg2 in the presence of 5 mM succinate and 200 nM RR,
washed, and assayed for ADP  ATP content and respiration.
As observed in Fig. 3B, this resulted in a rapid increase inmatrix
ADP  ATP in both genotypes, but much lower in SCaMC-
3-KO than in wild type mitochondria. These results emphasize
the role of SCaMC-3 in AdN “superfilling” and suggest that
under these conditions, other transport processes (including
pyrophosphatein/AdNout exchange on ANT) contribute to
refilling. In contrast with the results on AdN-depleted mito-
chondria, despite the large increase in the AdN pool, states 3
and 4 and uncoupled respiratory rates were unchanged regard-
less of the presence of SCaMC-3 (Fig. 4B).
FIGURE1.SCaMC-3 is themain functionalCa2-dependentATP-Mg/Pi carrier inadult liver.A,expression levels of themainSCaMCparalogswere analyzed
by Western blot in isolated mitochondria using different tissues from wild type (WT) and SCaMC-3-KO (KO) mice. -ATPase was used as loading control. B,
Western blot analysis of liver extracts from embryos (E14–E17), postnatal (P0–P4), and 3-month-old mice (3 mo) from wild type and SCaMC-3-KO mice.
Antibodies against SCaMC-1 and SCaMC-3, as well as Hsp60 as loading control, were used. Absence of SCaMC-3 did not induce up-regulation of other
ATP-Mg/Pi paralogs. C, respiratory rates were measured in isolated liver mitochondria from wild type and SCaMC-3-KO mice using substrates for complex I
(glumal) or complex II (succinate) in the presence (state 3, st. 3) or absence (state 4, st. 4) of 0.5mMADP. Respiratory control ratios (state 3/state 4; RCR) using
substrates for complex I or complex II are also shown. Results are expressed as mean S.E. of 8 (complex I) and 22 (complex II) independent experiments. D,
SCaMC-3 transports ATP-Mg in a Ca2-dependentway. Left panel showsATP uptake in isolated livermitochondria fromwild type and SCaMC-3-KOmice in the
presence or absence of Ca2. Mitochondria were incubated at 30 °C in the presence of 4 mM ATP, 5 mMMg2, and 200 nM RR, with 20 M Ca2 or 1 mM EGTA
in themedium, andmitochondrial ATP levels were determined. Results are expressed asmean S.E. of 3 independent experiments. In the right panel, kinetics
of Ca2 activation of ATP uptake in SCaMC-3 wild type liver mitochondria are shown. Data obtained were fitted by nonlinear regression to the following
equation: V V0 [((Vmax V0) [Ca
2]n)/(S0.5
n [Ca2]n)] (where V is transport activity at each [Ca2], V0 is the basal transport rate at 0 [Ca
2] (i.e.below the
Calcium-Greendetection limit),Vmax is themaximal activity,n is theHill index, andS0.5 is theCa
2 concentration that generates half-maximal transport activity)
using Sigma Plot version 9. Pooled data from 4 independent experiments are shown.
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Glucagon and Phenylephrine Exert Their Effects on Mito-
chondrial Respiration through SCaMC-3—Having shown that
SCaMC-3 is able to induce an increase in liver mitochondrial
AdN content and coupled respiration that does not occur in
SCaMC-3-KO mitochondria, we next studied whether this
mechanism is responsible for glucagon stimulation of mito-
chondrial respiration in hepatocytes (2). The stimulation by
glucagon of AdN uptake in liver mitochondria is dependent on
the generation of a Ca2 signal (4). Similarly, Ca2-mobilizing
agents like phenylephrine have been shown to increase the
mitochondrial AdN content in hepatocytes (37). In each case,
the nature of the Ca2 signals evoked is different and both ago-
nists are known to be synergistically potentiated (38). Fig. 4A
shows the effect of these agonists on cytosolic Ca2 in isolated
hepatocytes using fura2-AM. Transients elicited by 0.1M glu-
cagon show a delayed onset of about 2 min (Fig. 5A), whereas
addition of 100 M phenylephrine induces an immediate
increase in cytosolic Ca2(Fig. 5A). In both cases, cells that
show spontaneous oscillatory behavior before the addition
increase their oscillation frequency, whereas most of the nono-
scillatory cells start to oscillate (data not shown).No differences
were observed between genotypes.
We next studied the effect of glucagon and phenylephrine on
the oxygen consumption rate (OCR) of intact primary hepato-
cytes using a Seahorse Extracellular Flux Analyzer. Experi-
ments were performed using the layout represented in Fig. 5B.
Both genotypes showed similar basal rates normalized by pro-
tein content (1.9  0.7 nmol/min/mg in wild type cells versus
1.7 0.6 nmol/min/mg in SCaMC-3-deficient cells). Both glu-
cagon and phenylephrine cause an immediate stimulation of
the OCR in wild type cells of about 20% with respect to vehicle,
which is significantly lower (about 5%) in SCaMC-3-KO hepa-
tocytes (Fig. 5, C and D, agonist-induced stimulation). In wild
type cells most of this stimulation is due to an increase in cou-
pled respiration (i.e. oligomycin sensitive), particularly in the
case of glucagon, whereas neither of the two agonists increase
coupled respiration in SCaMC-3-KO cells (Fig. 5D, coupled
respiration). Glucagon also induces an increase of about 20% in
the maximal respiratory capacity (i.e. FCCP-stimulated respi-
ration) in hepatocytes from wild type mice, but not in those
from SCaMC-3-KOmice (Fig. 5, C andD, maximal respiratory
capacity). Phenylephrine effects onmaximal respiratory capac-
ity and coupled respiration followed the same trend but did not
reach statistical significance. Neither glucagon nor phenyleph-
rine have a significant effect on proton leak values in any of the
genotypes (Fig. 5D, proton leak). Taken together, these results
show that glucagon and phenylephrine induce a rapid increase
in mitochondrial respiration from intact primary hepatocytes
(particularly coupled respiration) and that this effect is largely
lost in hepatocytes that lack SCaMC-3.
AdN Uptake, CRC, and Stimulation of Respiration in Mito-
chondria after Glucagon Treatment in Vivo Is Mediated by
SCaMC-3—To verify that the effects found in isolated mito-
chondria and primary hepatocytes are also present in the intact
animal, we next studied the effect of in vivo administration of
glucagon, which has been shown to promote uptake of AdNs
and to stimulate respiration in livermitochondria (4, 39, 40). To
study the involvement of SCaMC-3 in this hormonal response,
we injected glucagon intraperitoneally in wild type and
SCaMC-3-KOmice and sacrificed them 15min later to analyze
liver mitochondrial AdN content and respiratory rates. Fig. 5A
shows that liver mitochondria from wild type mice undergo a
striking increase of about 50% in their AdN levels in response to
glucagon treatment, whereas the levels in SCaMC-3-KO mito-
chondria remain unaffected by the treatment. The increase is
not restricted to a particular AdN form, but rather affects all
three: AMP, ADP, and ATP (Fig. 6A, right panel). Interestingly,
under control (vehicle) conditions, ATP levels were found to be
lower in SCaMC-3-KO than in wild type mitochondria.
Although extraction procedures do not warrant that these con-
centrations correspond to real levels of the three AdNs in vivo,
they suggest that SCaMC-3 deficiencymight involve a decrease
in mitochondrial ATP levels. In fact, mouse embryonic fibro-
FIGURE 2. SCaMC-3 mediates the increase in Ca2 retention capacity in
liver mitochondria. Mitochondrial Ca2 uptake was monitored using the
fluorescent indicator Calcium Green-5N in the absence of AdNs in the
medium (A) or in the presence of 0.2 mM ADP (B) or 1 mM ATP-Mg (C). Arrows
indicate additions of 10 (A) or 20 (B and C) nmol of CaCl2. Quantification of
total Ca2 retained bymitochondria in each case is shown on the right side of
each panel. Results are expressed as mean S.E. of 3–5 independent exper-
iments (*, p 0.05; unpaired, two-tailed Student’s t test).
SCaMC-3 Is aMitochondrial Target of Glucagon
7796 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288•NUMBER 11•MARCH 15, 2013










blast derived from SCaMC-2-KO mice show lower cellular
ATP levels (30).
In the liver of fed rats, glucagon administration also leads to a
rapid increase in theCRC (41) andCa2 content (42) of rat liver
mitochondria. The increase in mitochondrial Ca2 plays a role
in activation of mitochondrial dehydrogenases and regulation
of respiration (43). Having found that SCaMC-3 is required to
increase CRC in response to AdN accumulation, we evaluated
whether SCaMC-3 may also be involved in increasing the CRC
of mitochondria in response to glucagon. Fig. 6B shows that
glucagon treatment results in a prominent increase in CRC in
liver mitochondria from wild type mice (compare Fig. 2A with
6B), which is essentially blunted in SCaMC-3-deficient mito-
chondria. Fig. 6C also shows that glucagon administration in
vivo stimulates state 4, state 3, and uncoupled respiration in
liver mitochondria using respiratory substrates of complex I or
II, but fails to do so in SCaMC-3-deficient mitochondria. As
previously described (44, 45), respiratory rates using TMPD
plus ascorbate as substrates were not affected by glucagon
administration, nor was complex IV activity (results not
shown). Therefore, the lack of SCaMC-3 blocks the responses
of liver mitochondria to glucagon in vivo, preventing AdN
accumulation, CRC increase, and stimulation of respiration.
DISCUSSION
We have shown that SCaMC-3 is the main mitochondrial
ATP-Mg/Pi transporter in adult liver from mice. We find that
SCaMC-3has an S0.5 forCa2 activation of 3.3 0.9M, a value
substantially lower than that of SCaMC-1 (12.7 5.3 M) (28)
or the yeast ATP-Mg/Pi carrier, Sal1p (15.0  1.1 M) (19).
Ca2 increases theVmax of these carriers with no changes in the
Km for the substrates, which are similar for both ATP-Mg and
ADP in all cases, ranging from 0.2 to 0.5 mM (10).
Previous studies have shown that the filling of themitochon-
dria with cytosolic AdNs during the first postnatal hours is
important in liver adaptation to an aerobic environment (46).
However, despite the fact that SCaMC-3 is the main paralog of
the carrier in adult liver, SCaMC-3-KO mice are born in men-
delian proportions, do not show obvious developmental
defects, and lack compensatory effects caused by up-regulation
of other mitochondrial transporters of ATP-Mg/Pi. This may
be explained by our finding that SCaMC-1 and SCaMC-3 are
both co-expressed in the embryonic and early postnatal liver,
and therefore, SCaMC-1 may compensate for the lack of
SCaMC-3 during postnatal development.
Glucagon is known to exert multiple effects on liver mito-
chondria including the increase in AdN content, respiration,
and CRC, as well as enhanced synthesis of citrulline and pyru-
vate carboxylation (43). Regarding the first of these effects, our
results have clarified how glucagon and phenylephrine cause an
increase in mitochondrial AdN content. To date, two hypothe-
ses had been proposed: in the first, Davidson and Halestrap (6)
suggested that Ca2 entry in the mitochondria could inhibit
matrix pyrophosphatase, leading to an increase in matrix pyro-
phosphate that would then be exchanged by cytosolic AdNs
through the ANT. The second mechanism, put forward by
Aprille and co-workers (2, 7), involves Ca2 activation of the
ATP-Mg/Pi carrier. Our data clearly support this latter hypoth-
esis, showing that the increase in liver mitochondrial AdNs in
response to glucagon does not take place in the absence of
SCaMC-3 (Fig. 6B), which is the only functional ATP-Mg/Pi
carrier in adult liver (Fig. 1).
Moreover, the present work also sheds light on the effect of
glucagon onmitochondrial CRC and its relationshipwithmito-
chondrial AdN content. In agreement with previous findings
related to SCaMC-1 (28) our results show that Ca2 activation
of AdN uptake through SCaMC-3 causes an accumulation of
matrixAdNs, which increasesmitochondrial CRC. Thismay be
due to the formation of Ca2-phosphate precipitates, as this
FIGURE3.AdditionofADPtoAdN-depletedmitochondria stimulates respiration throughSCaMC-3.Representative electrode traces and respiratory rates
of AdN-depleted liver mitochondria fromwild type (WT) and SCaMC-3-KOmice respiring on succinate and stimulated with 2mM ADP in the presence of Ca2
(A) or in the presence of 1 mM EGTA and 1 mM EDTA (B). State 3 respiratory rate and respiratory control ratio (RCR) are only stimulated in wild type liver
mitochondria in the presence of extramitochondrial Ca2. Results are expressed as mean S.E. of 3–5 independent experiments. *, p 0.05; **, p 0.01; WT
versus KO two-tailed, unpaired Student’s t test; #, p 0.05; ##, p 0.01; state 3 versus uncoupled two-tailed, paired Student’s t test. Scale bars: 10 nmol at O
(vertical) and 1 min (horizontal).
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process requires AdNs (47). Moreover, SCaMC-3 deficiency
prevents the increase in CRC caused by glucagon administra-
tion, showing that this effect of glucagon is mediated by
SCaMC-3.
We have shown that SCaMC-3 can regulate oxidative phos-
phorylation under certain conditions. We report a striking
effect of SCaMC-3-mediated Ca2-dependent uptake of ADP
or ATP-Mg in liver mitochondria, which effectively couples
respiration and OXPHOS, most likely by increasing the total
mitochondrial AdN pool. Previous studies have shown a bipha-
sic correlation between mitochondrial AdN content and respi-
ratory functions, which is especially steep when matrix AdN
levels are below 4 nmol/mg of protein, but becomesmoremod-
erate at higher concentrations (25). Our own results confirm
this dependence on the size of the AdN pool of state 3 respira-
tion at relatively low matrix AdN levels (Fig. 4A) but not at
higher AdN levels (Fig. 4B). It is important to note that RR was
present in these experiments, ruling out an effect of matrix
Ca2. Therefore, it is likely that the stimulation of respiration
observed by progressively increasing the AdN content is due to
FIGURE 4.Respiration inmitochondria loadedwithAdNs.A, wild type (WT) and SCaMC-3-KO (KO)mitochondriawere depleted fromAdNs and incubated at
30 °C in the presence of 200 nM RR, 2mM ATP, and 5mMMgCl2 for different lengths of time beforemonitoring state 4, state 3, and uncoupled respiratory rates
in the presence of 2 M rotenone plus 5 mM succinate. Respiratory control ratios (RCR) are also shown. The maximal increase of state 3 respiratory rate is
observed in wild type cells after 2 min of incubation. Results are expressed as mean S.E. of 5 independent experiments (*, p 0.05; **, p 0.01; two-tailed,
unpaired Student’s t test). B, nondepleted wild type and SCaMC-3-KOmitochondria were incubated at 30 °C in the presence of 200 nM RR, 10 mM ATP, 10 mM
MgCl2, and20MCaCl2 at different timesbeforemonitoring state 4, state 3, anduncoupled respiratory rates as inA. To correct for residual AdNs in themedium,
state 4 was that obtained after the addition of oligomycin. In parallel, mitochondrial levels of ATP ADP were also determined (bottom panel). Results are
expressed as mean S.E. of 3–5 independent experiments (*, p 0.05, two-tailed, unpaired Student’s t test).
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direct mass-action ratio effects of ADP and ATP on the ATP
synthase and/or the ANT. This stimulation may be important
in situations where mitochondrial AdN levels are low, like in
newborn liver and ischemic mitochondria, where even small
changes in the mitochondrial AdN content may bring about
significant changes in respiratory rates coupled to ATP synthe-
sis, as previously suggested by Aprille (5).
However, the mechanism whereby an increase in mitochon-
drial AdN content will increase coupled and maximal respira-
tion in the healthy adult liver, as occurs after treatment with
glucagon, is unclear. Asmentioned above, our results show that
beyond a certain threshold, further accumulation of adenine
nucleotides does not affect respiration rates. This contrasts
sharply with the consequences of the stimulation by glucagon
in intact hepatocytes and in vivo, where an increase in matrix
AdN content is associated with an increase both in coupled and
maximal uncoupled respiration, and a pronounced increase in
respiratory capacity in isolated mitochondria, all of which
require the presence of SCaMC-3.
The stimulation of respiration by glucagon has been the sub-
ject of a great amount of work during the 70s and 80s, although
the site of action of the hormone remains unknown. The
enhancement of oxygen consumption is observed when the
electron transport chain is fuelled with substrates of complex I
or complex II, but not when TMPD plus ascorbate are used
instead (44). It has been concluded that glucagon-induced acti-
vation of respiration involves increases in electron flow into the
ubiquinone pool and within complex III (48, 49). The mecha-
nism proposed for such stimulation is a moderate increase in
matrix volume caused by the uptake ofCa2 into themitochon-
dria following glucagon-induced cytosolic Ca2 signals. By
inhibiting mitochondrial pyrophosphatase activity, matrix
FIGURE 5. Effects of glucagon and phenylephrine on cytosolic Ca2 signals and respiratory parameters in primary hepatocytes from wild type and
SCaMC-3-KO animals. A, representative traces corresponding to cytoplasmic Ca2 concentration in primary wild type hepatocytes in response to 0.1 M
glucagon and 100 M phenylephrine addition. Light gray traces correspond to individual cells, whereas the average is represented by a black trace. In both
genotypes phenylephrine caused an immediate Ca2peak, whereas the effect of glucagonwas detectable 2min after its addition. The Ca2 signals evokedby
both agonists were identical in SCaMC-3-KO cells. B, a representative experiment of OCR in primary hepatocytes from wild type and SCaMC-3-KO and the
response to phenylephrine is shown. OCR is expressed as the rate at each point with respect to the basal rate at the time of addition of the agonist. Where
indicated, 100 M phenylephrine, 6 M oligomycin, 1 M FCCP, and 1 M rotenone plus 1 M antimycin A (rot  AntA) were injected. C, OCR responses to
phenylephrine (100M) and glucagon (0.1M) and the corresponding vehicle in hepatocytes fromWT and SCaMC-3 KOmice. Data correspond to represent-
ative experiments. D, respiratory parameters after treatment with 0.1 M glucagon or 100 M phenylephrine with respect to vehicle in wild type and SCaMC-
3-KOhepatocytes. Nonmitochondrial respiration (the lowest value remaining after rotenoneplus antimycinAaddition)was subtracted fromallmeasurements
after confirming that at longer times respiration was not further decreased. Respiratory parameters were calculated as the average of three consecutive
measurements after each addition (agonist, oligomycin, and FCCP). The stimulations of glucagon and phenylephrine and maximal respiratory capacity were
calculated as thepercentageof respiration after agonist or FCCP additionwith respect to basal respiration. Coupled respiration is thepercentageof respiration
in thepresenceof agonist sensitive tooligomycin inhibition. Proton leakwas calculated as thedifferencebetweenoligomycin-sensitive andnonmitochondrial
respiration. Results are expressed as mean  S.E. of 3 independent experiments with four replicates each (*, p  0.05; **, p  0.01; unpaired, two-tailed
Student’s t test, WT versus KO; #, p 0.01 ##, p 0.001 two-tailed Student’s t test, WT versus vehicle).
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Ca2 would cause an increase in pyrophosphate, in addition to
induce a K influx into the mitochondria through a K
uniporter whose nature is still debated (50). Matrix Ca2 itself
may control coupled respiration through matrix Ca2 activa-
tion of ATP synthase (51).
Therefore, it is possible that the increase in mitochondrial
CRCconferred by SCaMC-3 could explain the role of SCaMC-3
in glucagon signaling. By allowing Ca2 accumulation in mito-
chondria in vivo, SCaMC-3 might be permissive for K entry,
pyrophosphate accumulation in mitochondria, and/or other
glucagon targets, which would in turnmodulate the increase in
matrix volume and stimulate respiration (43).
A reduced CRC in mitochondria could also explain the dif-
ferent responses to glucagon and phenylephrine in SCaMC-3-
deficient hepatocytes. Whereas glucagon does not affect cou-
pled ormaximal respiration, phenylephrine tends to lower both
parameters in these cells. Phenylephrine-induced Ca2 signals
arise faster (Fig. 5A), are more persistent in time (52), and give
rise to larger changes in light scattering in isolated hepatocytes
than those of glucagon (49, 53), indicative of a higher require-
FIGURE6.SCaMC-3mediatesglucagon-stimulatedmitochondrial uptakeofAdNsand increase inCRCand respiratory activity in vivo. Following in vivo
administration of glucagon (2 mg/kg) or vehicle, liver mitochondria from wild type and SCaMC-3-KO mice were rapidly isolated and different mitochondrial
parameters were evaluated. A,matrix AdN content, measured by HPLC. Left panel shows total AdNs, whereas the right panel shows the levels of the different
AdNs. Results are expressed as mean S.E. of 3–5 independent experiments (*, p 0.05; WT versus KO, two-tailed, unpaired Student’s t test; #, p 0.05; WT
vehicle versus WT glucagon, one-tailed, unpaired Student’s t test). B, Ca2 retention in isolated mitochondria. Left panel shows a representative experiment,
with arrows corresponding to 10 nmol of CaCl2 additions. In the right panel, CRC is shown. Results are expressed asmean S.E. of 3 independent experiments
(*, p 0.05; WT versus KO, two-tailed, unpaired Student’s t test). C, state 4 (st. 4), state 3 (st. 3), and uncoupled (unc) respiratory rates using different substrates.
Results are expressed asmean S.E. of 6 independent experiments (*, p 0.05; vehicle versus glucagon, two-tailed paired Student’s t test; **, p 0.01; vehicle
versus glucagon, two-tailed paired Student’s t test).
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ment for CRC in mitochondria than for glucagon. It is feasible
that under these conditions, impaired Ca2 retention in
SCaMC-3-deficient mitochondria may hamper the respiratory
response to phenylephrine.
Interestingly, the present study provides indications that
SCaMC-3 is also required for the operation of the urea cycle.
Glucagon increases urea synthesis by activation of carbamoyl-
phosphate synthetase, a limiting step in this process (49), and it
has been proposed that increased ATP synthesis in mitochon-
dria may account for this effect of glucagon (5). Although we
have not measured blood ammonia, the drop in blood serum
urea levels found in SCaMC-3 KOmice (Table 1) could be due
to a limited function of the urea cycle in SCaMC-3 deficiency,
which in turn may be associated with a decreased content of
mitochondrial adenine nucleotides in response to glucagon.
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